Office-Based Labs

Partner with CSI for your Out-of-Hospital Practice

We are passionate about helping outpatient labs improve efficiencies, fuel growth and enhance patient outcomes.

How do we do it?

Proven Solutions

Full line of peripheral products to support your individualized approach to care with industry-leading support to guide you along the way

Reimbursement Advocacy

CSI supports initiatives to protect reimbursement and reduce preventable amputations through multiple partnerships, collaboration efforts and coalition engagement.

Educational Opportunities

Comprehensive courses, personalized proctorships, and CE certifications for staff

Patient Resources

Access to “Take a Stand” non-branded patient resources for PAD awareness

Support

Contact us to learn about CSI’s flexible pricing programs and how CSI can partner with you

Individualized Solutions for Treatment of PAD

Our growing portfolio of individualized solutions is designed to help you optimize treatment by providing you with the tools needed to access and treat complex peripheral lesions.

*Manufactured by OrbusNeich Medical Company Limited or its affiliates

Broad Range of Calcium


One Solution

ONLY ORBITAL ATEHRECTOMY BRINGS IT ALL TOGETHER

Calcium is common and is one of the biggest challenges you face with today’s complex peripheral artery disease (PAD) patients, which can decrease balloon and stent success1,2 and increase risk of adverse events.3 So it’s good to know that whenever mild to severe calcium is present, orbital atherectomy is the single solution you need to get from calcified to complaint, safely and efficiently.

Peripheral Atherectomy Solutions

Peripheral-Diamondback-Solid-Crown
Peripheral-Diamondback-Classic-Crown

2.00 Max Crown

  • Provides more engagement and luminal gain in mixed plaque above the knee.
  • Sizes: 2.00 mm

Solid Crown

  • The mass of the crown is designed for maximum calcium removal
  • Diamond-coated surface area allows for short run times

Classic Crown

  • The most flexible of our crown configurations
  • Designed for vessel bends, ostial lesions and distal below-the-knee procedures

Micro Crown

  • Designed with flexibility for tortuous vessels and tight bends below-the-knee
  • GlideAssist mode for the 1.25 Micro Crown enables the crown to spin at a slow speed (5k RPM) for easier tracking and removal of the device over the guide wire*
*CSI Data on File
pump

ViperWire Advance® and ViperWire Advance® with Flex Tip Peripheral Guide Wires

ViperWire Advance® and ViperWire Advance® with Flex Tip Peripheral Guide Wires are designed specifically for the Stealth 360® Peripheral Orbital Atherectomy Systems to facilitate proper device placement within the artery to enable orbital gain during treatment.

ViperSlide® Lubricant

ViperSlide is an exclusive lubricant for use with CSI’s Orbital Atherectomy Systems. ViperSlide increases the lubricity, therefore reducing friction between the device shaft and the ViperWire® Advance Guide Wire.

ViperTrack® Radiopaque Tape

ViperTrack adheres directly to the patient’s skin, providing accurate lesion measurement when using fluoroscopic or radiographic imaging.

OAS Pump

The OAS pump mounts directly onto an I.V. pole and provides power and the pumping mechanism for the Stealth  360®  Peripheral Orbital Atherectomy System.

DUAL-ACTION

Uniquely designed to enable simultaneous modification of both intimal and medial calcium.

VERSATILE

The low-profile design of our orbital atherectomy systems and unique extended length option can help you improve your procedural range and patient satisfaction.
IMPROVED CLINICAL EXPERIENCE
  • Low profile systems can reduce access site complications4 and allow for non-femoral access options, like transpedal
  • Transradial procedures with orbital atherectomy have a high rate of procedural and treatment success, as demonstrated in the REACH PVI study5
BETTER PATIENT EXPERIENCE

Alternative access procedures can:

  • Allow for a more comfortable recovery
  • Provide a shorter length of stay6
  • Improve the patient experience6
VIEW ADDITIONAL RESOURCES

PROVEN PROCEDURAL, CLINICAL AND ECONOMIC VALUE

The Stealth 360® Peripheral Orbital Atherectomy is designed to support procedural safety and efficiencies.

MINIMIZE DEVICES NEEDEDOne device can treat multiple lesions and vessels of different diameters.
LOW COMPLICATION RATESSmall sheath size can minimize access site complications and allow for radial and pedal access.
MINIMIZE FAILED ATTEMPTSStealth 360's diamond-like surface can break through calcium, and has a high rate of procedural success in many different lesion types.8
REDUCE ANCILLARY PRODUCTSSmall sheath size can minimize need for closure devices, and low rates of stent use8 can preserve future treatment options.
PROCEDURE EFFICIENCIESStealth 360 can be set up and ready to use in less than 2 minutes.

HIGH FREEDOM FROM
MAJOR LIMB AMPUTATION AT 3 YEARS7
KAPLAN-MIER ESTIMATE
$3,509 COST SAVINGS TO THE HEALTHCARE
SYSTEM AT 1 YEAR WITH OAS+PTA COMPARED TO PAT8
CLI PATIENT
  1. Shammas NW, et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the CALCIUM 360 randomized pilot trial. J Endovasc Ther. 2012 Aug;19(4):480-8.
  2. Rocha-Singh K, et al. Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv. 2014;83(6):E212-220.
  3. Fitzgerald PJ, et al. Contribution of localized calcium deposits to dissection after angioplasty. Circulation. 1992; 86(1):64-70.
  4. Bosiers M, et al. 4-French-compatible endovascular material is safe and effective in the treatment of femoropopliteal occlusive disease: results of the 4-EVER trial. J Endovasc Ther. 2013 Dec;20(6):746-56.
  5. Lodha A, et al. Transradial endovascular intervention: Results from the Radial accEss for nAvigation to your CHosen lesion for Peripheral Vascular Intervention (REACH PVI) study. Cardiovasc Revasc Med. 2022;36:115-120.
  6. Kwan T, et al. Feasiblity and safety of routine transpedal arterial access for treatment of PAD. J Invasive Cardiol 2015: 27(7):327-330.
  7. Giannopoulos S, et al. Three-year outcomes of orbital atherectomy for the endovascular treatment of infrainguinal claudication or chronic limb-threatening ischemia. J Endovasc Ther. 2020;27(5):714-725.
  8. Shammas NW, et al. Hospital cost impact of orbital atherectomy with angioplasty for critical limb ischemia treatment: a modeling approach. J Comp Eff Res. 2018 Apr;7(4):305-317.